DOCSLIB.ORG

Programme 2015

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Programme 2015 London on View The 5th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures 9-11 April 2015 London, United Kingdom Final Programme www.statusepilepticus2015.eu PATRONS Paracelsus Medical University Christian Doppler Klinik Ignaz Harrer Strasse 79 A-5020 Salzburg, Austria University College London Institute of Neurology Queen Square London WC 1N 3BG United Kingdom CHAIRS Simon Shorvon, London, United Kingdom Eugen Trinka, Salzburg, Austria 3 Contents Welcome Dear friends and colleagues, WELCOME ......................................................................................................................................... 5 Eugen Trinka Simon Shorvon GENERAL INFORMATION. ................................................................................................................ 6 It is our sincere pleasure to welcome you all to London, to this the 5th London-Innsbruck Col- Information FOR SPEAKERS & POSTER PRESENTERS................................................................... 8 loquium on Status Epilepticus and Acute Seizures. These meetings have taken place biennially since 2007, and have become an important fea- SCIENTIFIC PROGRAMME.................................................................................................................. 9 ture of the epilepsy calendar. ThursdaY, 9 APRIL 2015 ................................................................................................... 9 This year, the conference will focus on the clinical and experimental nature of status epilepti- cus and novel aspects of its treatment. It is our intention over the 3 days of the conference to FridaY, 10 APRIL 2015 ..................................................................................................... 12 have intensive and interactive discussion on the cutting edge of research and clinical practice in the field of status epilepticus. We hope to feature current basic and clinical research and to SaturdaY, 11 APRIL 2015 ............................................................................................... 14 provide up-to-date reviews of the field. The aim of the meeting is to stimulate thought and discussion, and to lead to improvements in the treatment and outcome of this condition. LIST OF FACULTY ........................................................................................................................... 16 We have deliberately left space in the programme for the audience to question and to chal- LIST OF POSTERS ........................................................................................................................... 22 lenge - for we believe, as a fundamental pillar of the Colloquia, that academic debate is at the heart of all learning and discovery. We hope you will all join in this endeavour and contribute POSTER ABSTRACTS ...................................................................................................................... 33 to what we hope will be a lively and instructive meeting. SPONSORS AND EXHIBITORS ......................................................................................................... 88 Finally, some acknowledgements are in order. First, we would like to thank our conference organizing team, led by Mrs Ina Kähler, from PCO Tyrol Congress for their tremendous work. Also, the academic activities of this conference would not have been possible without the generous support of our sponsors listed at the back page of this booklet, and we offer our sin- cere thanks to them all. We are grateful too for the patronage of this conference by University College London and Paracelsus Medical University Salzburg. With very best regards Eugen Trinka and Simon Shorvon Co-Chairs, 5th London-Innsbruck Colloquium on Status Epilepticus and Actue Seizures 4 5 General Information General Information Conference venue Coffee breaks and refreshments Great Hall, Sherfield Building Coffee and tea will be served during the official coffee breaks. Lunch will also be provided. All Imperial College, South Kensington Campus refreshments are served in the exhibition area. Londown SW7 2AZ, United Kingdom Smoking Registration Desk at Sherfield Building Smoking is prohibited inside the Sherfield Building. The registration will be located in the entrance area of the Sherfield Building, close to the Queen‘s Tower Rooms City Transportation Opening hours are as follows: Arriving by London Underground Thursday, 9 April 7:30 – 17:30 From South Kensington Station, the campus is only a five minute walk. The College is located Friday, 10 April 7:45 – 18:00 next to the Science Museum. Saturday, 11 April 8:15 – 16:15 Arriving by bus South Kensington Campus is easily accessible by bus. A number of routes pass within easy Congress Organisers walking distance of the campus. PCO Tyrol Congress Congress und Messe Innsbruck GmbH Currency Ms. Ina Kähler and Ms. Sarah Fechner The official currency in the United Kingdom is the Pound. Major credit cards are accep- Rennweg 3 ted in most hotels, shops and restaurants. Automatic teller machines (ATMs) are available 6020 Innsbruck, Austria throughout the city. T: +43-(0)512-575600, F:+43-(0)512-565707 E: [email protected] Name Badges I: www.pco-tyrolcongress.at, www.cmi.at All registered participants receive a name badge together with their registration documents. Please make sure to wear your badge at all times while attending the meeting, exhibition and Trade Exhibition social events. A trade exhibition of pharmaceutical companies and manufacturers of medical equipment is held in the Queen‘s Tower Rooms. Liability and Insurance Neither the organisers, nor the congress secretariat or other suppliers accept liability for per- Exhibition Organisers sonal injuries or loss or damage of property belonging to congress delegates, either during or S12! studio 12 GmbH as a result of the Congress. It is recommended that participants arrange for their own personal Mr. Ralph Kerschbaumer health, accident and travel insurance. Kaiser Josef Straße 9 6020 Innsbruck, Austria Social Programme T: +43-(0)512-890438, F: +43-(0)512-890438-15 Conference Dinner at the Royal College of Physicians (RCP) E: [email protected] Food nourishes the brain and the soul, and at this the 2015 meeting, a rather splendid recep- tion and dinner will be held at the Royal College of Physicians. In addition, there will be an Certificate of Attendance opportunity also to visit the famous building of the College, see items from the College’s mu- All registered delegates receive an official certificate of attendance together with their regis- seum and library, and also to view the temporary exhibition of paintings of medicinal plants. tration documents. Tickets are at EUR 55,00 p.p. Pre-booking is required as tickets are limited! Cloakroom The cloakroom is located on the first floor of the Sherfield Building. 6 7 Information for Speakers & Poster Presenters Scientific Programme Information for speakers THURSDAY APRIL 9th 2015 The Great Hall is equipped with a data projector and a PC for PowerPoint presentations. Please make sure to bring your PowerPoint presentation on a USB-stick to the media check well in 08.30 - 12.30 THE NATURE OF SE: EXPERIMENTAL ASPECTS advance, 2 hours prior to the start of your session at the very latest. Do not bring your own laptop for the presentation. Chair: D. Kullmann (United Kingdom) and J. Kapur (USA) In case your presentation contains video sequences, please ensure to pack them with a stan- dard codec and do not store them in a Quick Time format since this may not be compatible 08.30 - 08.40 Welcome and introduction with PowerPoint presentations. S. Shorvon (United Kingdom) and E. Trinka (Austria) In order to be able to keep the time schedule, please make sure not to exceed the allotted 08.40 - 09.15 Is hypoxia important in status epilepticus? speaking time. G. Biagini (Italy) 09.15 – 09.50 Structural and functional changes in astrocytes following status epilepticus Information for poster presenters K. Wilcox (USA) The poster session is held on Friday, 10th April from 11:55 – 14:00 in the Queen‘s Tower Rooms 09.50 - 10.20 Coffee Break (Sherfield Building). Chair: D. Lowenstein (USA) and A. Rossetti (Switzerland) POSTER FORMAT: Your poster should not exceed 90 cm in width and 150 cm in height (portrait NOT landscape 10.20 – 10.55 What are the physiological bases of GPEDs and other format). Mounting material will be provided on site. EEG patterns in status epilepticus? All posters will be displayed during the entire congress and should be mounted on 9th April in M. van Putten (The Netherlands) the morning. Posters have to be displayed during the whole congress and have to be taken down on Saturday 11th April by the end of the colloquium. Please note that all posters which 10.55 - 11.30 Is spreading depression important in status have not been taken down by their presenters will automatically be removed and discarded. epilepticus? J. Dreier (Germany) POSTER PRESENTATION DETAILS: During the session you or one of your co-authors must be at your poster site and be prepared 11.30 - 12.05 What does burst suppression really mean? to answer questions. F. Amzica (Canada) 12.05 – 12.30 Lunch 8 9 Scientific Programme Scientific Programme 12.30 – 13.30 SATELLITE SYMPOSIUM: 15.00 - 15.30 P2X receptor as a link between hyperexcitability and STATUS EPILEPTICUS – FROM BENCH TO BEDSIDE – neuroinflammation in status epilepticus CHALLENGES FOR TRANSLATING NEW MECHANISMS INTO D. Henshall (Ireland) NEW TREATMENTS (Sponsored by
Load more

Recommended publications
  • Re-Evaluation of the Architecture Built During the 1920-1940 Period In
    Re-evaluation of the Architecture built during the 1920-1940 period in Meran/o, South Tyrol, Italy. A dissertation submitted to Manchester School of Architecture, a joint school between The University of Manchester and Manchester Metropolitan University, for the degree of Master of Architecture (MArch RIBA Part II) Vanessa Torri 15110222 Manchester School of Architecture Academic Year 2015/2016 DECLARATION This dissertation is the author’s original work and no portion of the work referred to in the dissertation has been submitted in support of an application for another degree or qualification of this or any other university or other institute of learning. INTELLECTUALPROPERTY STATEMENT i. The author of this dissertation (including any appendices and/or schedules to this dissertation) owns certain copyright or related rights in it (the “Copyright”) and s/he has given The University of Manchester certain rights to use such Copyright, including for administrative purposes. ii. Copies of this dissertation, either in full or in extracts and whether in hard or electronic copy, may be made only in accordance with the Copyright, Designs and Patents Act 1988 (as amended) and regulations issued under it or, where appropriate, in accordance with licensing agreements which the University has entered into. This page must form part of any such copies made. iii. The ownership of certain Copyright, patents, designs, trademarks and other intellectual property (the “Intellectual Property”) and any reproductions of copyright works in the dissertation, for example graphs and tables (“Reproductions”), which may be described in this dissertation, may not be owned by the author and may be owned by third parties.
    [Show full text]
  • Introduction
    FLUSSER STUDIES 28 Introduction The current issue of Flusser Studies considers Flusser’s first three years in Europe and focuses on Merano/Meran in northern Italy. There, Vilém and Edith spent the falls and winters between October 1972 and May 1975, reading and writing in a more or less quiet ambience. As Flusser wrote in a letter to Abraham Moles on December 4 1973 „All very well, but what should we be doing? My answer: stay put in Merano or a farmhouse near Strasbourg, write books and articles nobody will read, talk together about God and the world, and have a nice time as the fires are burning. I invite you to do this with us“.1 However, this account of a time of rest and intellectual work cannot hide the evidence of considerable activity. During this time, Flusser published several essays in the leading German newspaper of Alto Adige/Südtirol in northern Italy, Dolomiten, and one article for Das Fenster of North Tyrol in Austria. These quickly brought him into a number of contemporary multilingual discussions. The essays reprinted here date from that time in the early 1970s and make reference to the immediate context. It is worth noting that 1972 was exactly the year Alto Adige/Südtirol / South Tyrol (officially: Provincia Autonoma di Bolzano/ Autonome Provinz Bozen/Provinzia Autonoma de Balsan/Bulsan) successfully adopted a policy of détente. As Flusser had several well-informed and educated friends in Italy, and as the Italian and German newspapers frequently reported on the issue, he must have known details of those developments.
    [Show full text]
  • 31St International Epilepsy Congress Istanbul, Turkey 5Th – 9Th September 2015
    ABSTRACTS 31st International Epilepsy Congress Istanbul, Turkey 5th – 9th September 2015 Epilepsia, 56(Suppl. 1):3–263, 2015 doi: 10.1111/epi.13241 Platform Session: Basic Science 0002 Sunday, 6th September 2015 MORPHOLOGICAL CHANGES IN EEG, AQUAPORIN- 4, C-FOS AND THE HIPPOCAMPUS OF ANIMAL 0001 MODELS WITH TEMPORAL LOBE EPILEPSY SODIUM SELENATE RETARDS EPILEPTOGENESIS INDUCED BY KAINIC ACID ı † † † ‡ VIA ACTIVATING PROTEIN PHOSPHATASE 2A E. Taskiran*,C.Ylmaz , N. Orhan , M. Bahceci , M. Kaya , B. Ahishali‡, M. Kucuk†, N. Arican‡, C. Gurses§ P. Zheng*, S. Liu*, N. Jones*, S. Shultz*, G. Dezsi*, D. Wright†, *Neurology Department, Istanbul Medipol University, Istanbul, C. Hovens‡, T.J. O’Brien*,§ † *The Royal Melbourne Hospital, Medicine, Melbourne, Turkey, Istanbul University, Research Institute of Experimental Medicine, Istanbul, Turkey, ‡Istanbul University Istanbul Australia, †The Florey Institutes of Neuroscience and Mental Faculty of Medicine, Istanbul, Turkey, §Department of Health, Melbourne, Australia, ‡The Royal Melbourne Hospital, Surgery, Melbourne, Australia, §Melbourne Brain Centre, Neurology and Clinical Neurophysiology, Istanbul University, Neurology, Melbourne, Australia Istanbul Faculty of Medicine, Istanbul, Turkey Purpose: Temporal lobe epilepsy (TLE) is the most frequent type of Purpose: Epileptogenesis describes the neurobiological processes that localization-related focal epilepsy seen in humans. It has a frequency rate convert a healthy brain into an epileptic brain. There are no treatments of 30–35% among all epilepsies, and comprises 70% of intractable available to mitigate epileptogenesis in clinical practice. Down-regula- epilepsies. With hippocampal sclerosis as the most often observed tion of protein phosphatase 2A (PP2A) activity increases phosphorylated histopathological finding, its epileptogenesis is still researched. tau (p-tau), which is implicated in acquired epilepsy.
    [Show full text]
  • 001 | Cerebrospinal Fluid Profile in Epilepsy Considering Exclusion Of
    DOI: 10.1111/epi.14612 ABSTRACT ADULT EPILEPTOLOGY etiology and seizure type. This is most important to prevent 27 AUGUST 2018 misinterpretation of postictal phenomena of CSF parame- ters. Nevertheless, one should note, that mild pleocytosis 001 | Cerebrospinal Fluid Profile in Epilepsy and/or intrathecal Ig is found only in a minor percentage of patients, indicating careful exclusion of alternative reasons Considering Exclusion of an Autoimmune Origin for alterations in CSF profile. M. Süße*, N. Saathoff†, M. Hannich*, C. Holbe*, A. Dressel‡, A. Flöel§, F. von Podewils* *University Medicine Greifswald, Neurology/Epileptology, Greifswald, Germany; †University Medicine Greifswald, Greifswald, Germany; 002 | Automated Free‐Water Imaging Analysis ‡ § Carl‐Thiem Klinikum Cottbus, Neurology, Cottbus, Germany; University in Patients with Epilepsy and Focal Cortical Medicine Greifswald, Neurology, Greifswald, Germany Dysplasia Purpose: Analyzing cerebrospinal fluid (CSF) is crucial in B.A.K. Kreilkamp*,†, O. Pasternak‡, K. Das†, U.C. Wieshmann†, † ,† ,† the diagnostic workup of epileptic seizures, in particular to S. Biswas , A.G. Marson* , S.S. Keller* *University of Liverpool, Liverpool, United Kingdom; †The Walton Centre investigate the occurrence of infectious diseases or autoim- ‡ mune epilepsy in cases of encephalitis. It is, therefore, essen- NHS Foundation Trust, Liverpool, United Kingdom; Harvard Medical School, Boston, ME, United States tial to characterize CSF changes caused by epileptic seizures to understand etiological associated pathogenic alterations in Purpose: Focal cortical dysplasia (FCD) may escape neuro- CSF profile. Existing systematic investigations differ in radiologist assessment [Martin et al. QIMS 2015;5(2):188– result and methodology; also the systematic exclusion of 203]. Quantitative lesion detection usually relies on T1w and autoimmune encephalitis is lacking in present studies.
    [Show full text]
  • Literatur-Dauerrecherche Multiple Sklerose Ausgabe Februar 2018
    Literatur-Dauerrecherche – 1 – Multiple Sklerose: Veröffentlichungen Oktober 2013 Literatur-Dauerrecherche Multiple Sklerose Ausgabe Februar 2018 Die Literatur-Dauerrecherche finden Sie zum Download auch auf unserer Internetseite http://www.betaferon.de nach der Anmeldung unter dem Reiter „Aktuelle Informationen“, Menüpunkt „MS-Literaturupdate“. Bayer Vital GmbH, Specialty Medicine http://www.gesundheit.bayer.de http://www.betaferon.de Ungefiltert, unredigiert und nach Journals sortierthttp://www.ms -gateway.de Quelle: Public Medline; 288 Abstracts (=Neuaufnahmen in der Literaturdatenbank) Längste Therapieerfahrung 1,2,3,4 EDSS – Berufstätigkeit – Kognition BETAPLUS® Persönliche Patienten-Betreuung BETACONNECT® Innovative Injektionshilfe MEHR ALS 25 JAHRE KLINISCHE ERFAHRUNG 1 Goodin D et al., Neurology 2012;78:1315–1322, 2 Ebers G et al., JNNP 2010;81:907-912, 3 Kappos L et al.,Poster M1715WIP, ANA 2014, 4 Edan G et al., Poster P7.012,AAN 2015 Betaferon® 250 Mikrogramm/ml, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung. Wirkstoff: Interferon beta-1b (Vor Verschreibung bitte die Fachinformation beachten.) Zusammensetzung: Arzneilich wirksamer Bestandteil: 1 ml der gebrauchsfertigen Injektionslösung enthält 250 Mikrogramm (8,0 Mio. I.E.) rekombinantes Interferon beta-1b. 1 Durchstechfl asche enthält 300 Mikrogramm (9,6 Mio. I.E.) rekombinantes Interferon beta-1b. Sonstige Bestandteile: Pulver für Injektionslösung: Albumin vom Menschen, Mannitol, Lösungsmittel: Natriumchloridlösung 0,54 % G/V. Anwendungsgebiete: Betaferon®
    [Show full text]